Home › Peripheral Arterial Disease › Alabama
Peripheral Arterial Disease clinical trials in Alabama
4 studies for Peripheral Arterial Disease are looking for participants at sites in Alabama.
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Lake Martin Medical and Vascular Center, Alexander City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07318610Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- St. Vincent's Birmingham Hospital, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07223593Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Nephrology of North Alabama, Decatur
- Nephrology Consultants, LLC, Huntsville
- DaVita Clinical Research Montgomery, Montgomery
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
Recruiting
Ages 21 and older · All sexes · Updated May 6, 2026 · NCT06033924From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.